Please use this identifier to cite or link to this item: http://hdl.handle.net/2381/45184
Title: Association of pre-eclampsia risk with maternal levels of folate, homocysteine and vitamin B12 in Colombia: A case-control study
Authors: Serrano, NC
Quintero-Lesmes, DC
Becerra-Bayona, S
Guio, E
Beltran, M
Paez, MC
Ortiz, R
Saldarriaga, W
Diaz, LA
Monterrosa, Á
Miranda, J
Mesa, CM
Sanin, JE
Monsalve, G
Dudbridge, F
Hingorani, AD
Casas, JP
First Published: 6-Dec-2018
Publisher: Public Library of Science
Citation: PLoS ONE, 2018, 13(12): e0208137
Abstract: Background Maternal serum concentrations of folate, homocysteine, and vitamin B12 have been associated with pre-eclampsia. Nevertheless, reported studies involve limited number of cases to reliably assess the nature of these associations. Our aim was to examine the relation of these three biomarkers with pre-eclampsia risk in a large Colombian population. Materials and methods Design: A case-control study. Setting: Cases of pre-eclampsia and healthy pregnant controls were recruited at the time of delivery from eight different Colombian cities between 2000 and 2012. Population or Sample: 2978 cases and 4096 controls were studied. Maternal serum concentrations of folate, homocysteine, and vitamin B12 were determined in 1148 (43.6%) cases and 1300 (31.7%) controls. Also, self-reported folic acid supplementation was recorded for 2563 (84%) cases and 3155 (84%) controls. Analysis: Adjusted odds ratios (OR) for pre-eclampsia were estimated for one standard deviation (1SD) increase in log-transformed biomarkers. Furthermore, we conducted analyses to compare women that reported taking folic acid supplementation for different periods during pregnancy. Main Outcomes Measures: Odds ratio for pre-eclampsia. Results After adjusting for potential confounders in logistic regression models, the OR for pre-eclampsia was 0.80 (95% CI: 0.72, 0.90) for 1SD increase in log-folate, 1.16 (95%CI: 1.05, 1.27) for 1SD increase in log-homocysteine, and 1.10 (95%CI: 0.99, 1.22) for 1SD increase in log-vitamin B12. No interactions among the biomarkers were identified. Women who self-reported consumption of folic acid (1 mg/day) throughout their pregnancy had an adjusted OR for pre-eclampsia of 0.86 (95%CI: 0.67, 1.09) compared to women that reported no consumption of folic acid at any point during pregnancy. Conclusions Maternal serum concentrations of folate were associated as a protective factor for pre-eclampsia while concentrations of homocysteine were associated as a risk factor. No association between maternal vitamin B12 concentrations and preeclampsia was found.
DOI Link: 10.1371/journal.pone.0208137
eISSN: 1932-6203
Links: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0208137
http://hdl.handle.net/2381/45184
Version: Publisher Version
Status: Peer-reviewed
Type: Journal Article
Rights: Copyright © the authors, 2018. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Description: The data from this study is available under request since we have not clearance from the Ethics Committee to make the database public. The contact information to request the data, if needed, is Dr. Claudia Yaneth Uribe Perez (curibep@unab.edu.co), who is the Chair of the Ethics Review Board of Universidad Autónoma de Bucaramanga.
Appears in Collections:Published Articles, Dept. of Health Sciences

Files in This Item:
File Description SizeFormat 
journal.pone.0208137.pdfPublished (publisher PDF)1.05 MBAdobe PDFView/Open


Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.